FAQ
Q: What is the difference between adaptive immune response and innate immune activation? Which
topic should I study first?
+
A: Innate immunity is more like an "alarm system" (PRR recognition,
pro-inflammatory factors, type I interferons), while adaptive immunity involves "specific clearance and
memory" (T cells/B cells/antibodies). If you are still unsure whether the stimulus has been recognized
or if the model has been activated, it is recommended to first check
Topic
2: Activation of Innate Immunity If you have already observed an increase in innate readings,
the next step is more suitable for evaluation using this topic.
T/B Cell Effector Functions and
Antibody Responses.
Q: How can I quickly determine "whether there is a T-cell response"?
+
A: The most commonly used quick combination is
IL-2 + IFN-γ：
- IL-2 leans more towards "expansion/persistence potential."
- IFN-γ leans more toward "effector output (Th1/cytotoxic-related context)."
If there is no significant change in either of these, it typically indicates
that the T-cell response has not yet been established or the time window has not been covered.
Q: Question 2: Why use CXCL10 (IP-10) when entering the effect period accompanied by chemotactic
recruitment signals?
+
A: Since CXCL10 is a typical IFN-induced chemokine, it is often used to
indicate "whether there is a recruitment signal background." Note that it reflects Chemotactic
environmental signals, It is not a direct proof that "the number of certain cells must
increase." If you need to demonstrate infiltration/migration, it is recommended to combine histological
or cytological evidence.
Q: If I only want to select two indicators for initial screening, how can I choose more
reliably?
+
A: LookYouResearch Objective:
- T-cell response initiation: IL-2 + IFN-γ
- Effect Output + Recruitment Background: IFN-γ + CXCL10
- B Cell/Humoral Immunity Direction: IgG + (optional IL-4 or IL-21)
Q: I see that IFN-γ is very high, but IL-2 is not high. What does this mean?
+
A: A common explanation is: it has appeared. Effect Output However,
the potential for "amplification/sustained response" may be insufficient or fall within different time
windows. It is recommended to extend the time points (e. g., early/mid/late) or incorporate a
"background factor" (such as TNF-α) in the enhanced version to assist in assessing the overall
inflammatory intensity.
Q: Should I use serum/plasma or cell supernatant to evaluate adaptive immune responses?
+
A:
- Serum/Plasma: More suitable for observing antibody levels and systemic
cytokine trends (closer to overall outcomes).
- Cell supernatant (post-stimulation): More suitable for mechanism
determination (e. g., whether IL-2/IFN-γ is released after antigen stimulation). If you are
conducting animal immunization or vaccine evaluation, the common practice is: serum for
antibodies + supernatant for cytokines (clearer division of labor).
